NIAID Banner Logo Image

Mycobacterium Citations List: January, 2017

Literature Citations

1. Antimycobacterial Activity of Novel Hydrazide-hydrazone Derivatives with 2H-Chromene and Coumarin Scaffold. Angelova, V.T., V. Valcheva, N.G. Vassilev, R. Buyukliev, G. Momekov, I. Dimitrov, L. Saso, M. Djukic, and B. Shivachev. Bioorganic & Medicinal Chemistry Letters, 2017. 27(2): p. 223-227. PMID[27914798].
[PubMed]. TB_01_2017.


2. Lanthanide Benzoates with 2,6-di-tert-Butylphenol Moiety: Synthesis, Luminescent and Antioxidant Properties. Antonenko, T.A., D.B. Shpakovsky, Y.A. Gracheva, T.V. Balashova, A.P. Pushkarev, M.N. Bochkarev, and E.R. Milaeva. Inorganica Chimica Acta, 2017. 455: p. 276-282. ISI[000389167100035].
[WOS]. TB_01_2017.


3. Synthesis, Screening and Docking Analysis of Hispolon Analogs as Potential Antitubercular Agents. Balaji, N.V., B. Hari Babu, G.V. Subbaraju, K. Purna Nagasree, and M. Murali Krishna Kumar. Bioorganic & Medicinal Chemistry Letters, 2017. 27(1): p. 11-15. PMID[27894872].
[PubMed]. TB_01_2017.


4. Synthesis and Antimicrobial Activity of Novel 5-Substituted-N-(substituted-2H-[1,3]oxazino[6,5-b]quinolin-3(4H)-y1)-3-phenyl-1H-indole-2-carboxamides. Basavarajaiah, S.M. and B.H.M. Mruthyunjayaswamy. Indian Journal of Chemistry, 2016. 55(12): p. 1511-1519. ISI[000390631100003].
[WOS]. TB_01_2017.


5. In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium avium Complex. Brown-Elliott, B.A., J.V. Philley, D.E. Griffith, F. Thakkar, and R.J. Wallace, Jr. Antimicrobial Agents and Chemotherapy, 2017. 61(2): e01798-16. PMID[27872065]. PMCID[PMC5278735].
[PubMed]. TB_01_2017.


6. DNA Sequence-selective C8-linked Pyrrolobenzodiazepine Heterocyclic Polyamide Conjugates Show Anti-tubercular-specific Activities. Brucoli, F., J.D. Guzman, M.A. Basher, D. Evangelopoulos, E. McMahon, T. Munshi, T.D. McHugh, K.R. Fox, and S. Bhakta. Journal of Antibiotics, 2016. 69(12): p. 843-849. PMID[27168314].
[PubMed]. TB_01_2017.


7. Synthesis, Antitubercular and Leishmanicidal Evaluation of Resveratrol Analogues. Coimbra, E.S., J.A. Santos, L.L. Lima, P.A. Machado, D.L. Campos, F.R. Pavan, and A.D. Silva. Journal of the Brazilian Chemical Society, 2016. 27(12): p. 2161-2169. ISI[000391146000001].
[WOS]. TB_01_2017.


8. Structure-based Virtual Screening to Get New Scaffold Inhibitors of the Ser/Thr Protein Kinase PknB from Mycobacterium tuberculosis. Coluccia, A., G. La Regina, N. Barilone, M.N. Lisa, A. Brancale, G. Andre-Leroux, P.M. Alzari, and R. Silvestri. Letters in Drug Design & Discovery, 2016. 13(10): p. 1012-1018. ISI[000389464700004].
[WOS]. TB_01_2017.


9. Stereoselective Synthesis, Docking, and Biological Evaluation of Difluoroindanediol-based Mene Inhibitors as Antibiotics. Evans, C.E., J.S. Matarlo, P.J. Tonge, and D.S. Tan. Organic Letters, 2016. 18(24): p. 6384-6387. PMID[27978658]. PMCID[PMC5171203].
[PubMed]. TB_01_2017.


10. Antitubercular Activity of 1,2,3-Triazolyl Fatty acid Derivatives. Ghiano, D.G., A. de la Iglesia, N. Liu, P.J. Tonge, H.R. Morbidoni, and G.R. Labadie. European Journal Medicinal Chemistry, 2017. 125: p. 842-852. PMID[27750201]. PMCID[PMC5148633].
[PubMed]. TB_01_2017.


11. Identification of Mycobacterium tuberculosis Leucyl-tRNA Synthetase (LeuRS) Inhibitors among the Derivatives of 5-Phenylamino-2H-[1,2,4]triazin-3-one. Gudzera, O.I., A.G. Golub, V.G. Bdzhola, G.P. Volynets, O.P. Kovalenko, K.S. Boyarshin, A.D. Yaremchuk, M.V. Protopopov, S.M. Yarmoluk, and M.A. Tukalo. Journal of Enzyme Inhibition and Medicinal Chemistry, 2016. 31(sup2): p. 201-207. PMID[27241561].
[PubMed]. TB_01_2017.


12. Biofabrication of Polyphenols Stabilized Reduced Graphene oxide and Its Anti-tuberculosis Activity. Han, W., W.Y. Niu, B. Sun, G.C. Shi, and X.Q. Cui. Journal of Photochemistry and Photobiology B-Biology, 2016. 165: p. 305-309. PMID[27838484].
[PubMed]. TB_01_2017.


13. Design, Synthesis and Evaluation of Diphenyl ether Analogues as Antitubercular Agents. Inturi, B., G.V. Pujar, M.N. Purohit, V.B. Iyer, G.S. Sowmya, and M. Kulkarni. RSC Advances, 2016. 6(112): p. 110571-110582. ISI[000389463600014].
[WOS]. TB_01_2017.


14. Synthesis, Biological Evaluation and in Silico Molecular Modeling of Pyrrolyl Benzohydrazide Derivatives as Enoyl ACP Reductase Inhibitors. Joshi, S.D., S.R. Dixit, V.H. Kulkarni, C. Lherbet, M.N. Nadagouda, and T.M. Aminabhavi. European Journal of Medicinal Chemistry, 2017. 126: p. 286-297. PMID[27889632].
[PubMed]. TB_01_2017.


15. Synthesis and Structure-activity Studies of Side Chain Analogues of the Anti-tubercular Agent, Q203. Kang, S., Y.M. Kim, R.Y. Kim, M.J. Seo, Z. No, K. Nam, S. Kim, and J. Kim. European Journal of Medicinal Chemistry, 2017. 125: p. 807-815. PMID[27750198].
[PubMed]. TB_01_2017.


16. S-Substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as Highly Efficient Antitubercular Agents. Karabanovich, G., J. Nemecek, L. Valaskova, A. Carazo, K. Konecna, J. Stolarikova, A. Hrabalek, O. Pavlis, P. Pavek, K. Vavrova, J. Roh, and V. Klimesova. European Journal of Medicinal Chemistry, 2017. 126: p. 369-383. PMID[27907875].
[PubMed]. TB_01_2017.


17. Biological Evaluation of Small Molecule Inhibitors of Mtb-ASADH Enzyme. Kumar, R., R. Sethi, P. Shah, I. Roy, I.P. Singh, P.V. Bharatam, R. Tewari, and P. Garg. Letters in Drug Design & Discovery, 2016. 13(7): p. 587-590. ISI[000389462100002].
[WOS]. TB_01_2017.


18. Pyrazolo[1,5-a]pyridine-3-carboxamide Hybrids: Design, Synthesis and Evaluation of Anti-tubercular Activity. Lu, X.Y., J. Tang, S.Y. Cui, B.J. Wan, S.G. Franzblauc, T.Y. Zhang, X.T. Zhang, and K. Ding. European Journal of Medicinal Chemistry, 2017. 125: p. 41-48. PMID[27654393].
[PubMed]. TB_01_2017.


19. Integration of Ligand and Structure Based Approaches for Identification of Novel MbtI Inhibitors in Mycobacterium tuberculosis and Molecular Dynamics Simulation Studies. Maganti, L., P. Grandhi, and N. Ghoshal. Journal of Molecular Graphics & Modelling, 2016. 70: p. 14-22. PMID[27639087].
[PubMed]. TB_01_2017.


20. Synthesis and Biological Evaluation of Phosphate Isosters of Fosmidomycin and Analogs as Inhibitors of Escherichia coli and Mycobacterium smegmatis 1-Deoxyxylulose 5-phosphate Reductoisomerases. Munier, M., D. Tritsch, F. Krebs, J. Esque, A. Hemmerlin, M. Rohmer, R.H. Stote, and C. Grosdemange-Billiard. Bioorganic & Medicinal Chemistry, 2017. 25(2): p. 684-689. PMID[27955925].
[PubMed]. TB_01_2017.


21. Lauric acid and Myristic acid from Allium sativum inhibit the Growth of Mycobacterium tuberculosis H37Ra: In Silico Analysis Reveals Possible Binding to Protein Kinase B. Muniyan, R. and J. Gurunathan. Pharmaceutical Biology, 2016. 54(12): p. 2814-2821. PMID[27307092].
[PubMed]. TB_01_2017.


22. In Search of Tuberculosis Drug Design: An in Silico Approach to Azoimidazolyl Derivatives as Antagonist for Cytochrome P450. Pradhan, S., S. Mondal, and C. Sinha. Journal of the Indian Chemical Society, 2016. 93(9): p. 1067-1084. ISI[000389966600006].
[WOS]. TB_01_2017.


23. Synthesis, Characterization and Biological Activity of Fluorescently Labeled Bedaquiline Analogues. Rombouts, J.A., R.M.P. Veenboer, C. Villellas, P. Lu, A.W. Ehlers, K. Andries, A. Koul, H. Lill, E. Ruijter, R.V.A. Orru, K. Lammertsma, D. Bald, and J.C. Slootweg. RSC Advances, 2016. 6(110): p. 108708-108716. ISI[000389342800066].
[WOS]. TB_01_2017.


24. Quinolidene-Rhodanine Conjugates: Facile Synthesis and Biological Evaluation. Subhedar, D.D., M.H. Shaikh, B.B. Shingate, L. Nawale, D. Sarkar, V.M. Khedkar, F.A.K. Khan, and J.N. Sangshetti. European Journal of Medicinal Chemistry, 2017. 125: p. 385-399. PMID[27688192].
[PubMed]. TB_01_2017.


25. Small-molecule Probes Reveal Esterases with Persistent Activity in Dormant and Reactivating Mycobacterium tuberculosis. Tallman, K.R., S.R. Levine, and K.E. Beatty. ACS Infectious Diseases, 2016. 2(12): p. 48-56. PMID[27690385].
[PubMed]. TB_01_2017.


26. Targeting Intracellular P-Aminobenzoic acid Production Potentiates the Anti-tubercular Action of Antifolates. Thiede, J.M., S.L. Kordus, B.J. Turman, J.A. Buonomo, C.C. Aldrich, Y. Minato, and A.D. Baughn. Scientific Reports, 2016. 6(38083): 8pp. PMID[27905500]. PMCID[PMC5131483].
[PubMed]. TB_01_2017.


27. Ecofriendly Synthesis and Biological Evaluation of 4-(4-Nitro-phenyl)-2-phenyl-1,4-dihydro-benzo[4,5]imidazo[1,2-a]pyrimidine-3-carboxylic acid ethyl ester Derivatives as an Antitubercular Agents. Warekar, P.P., P.T. Patil, K.T. Patil, D.K. Jamale, G.B. Kolekar, and P.V. Anbhule. Synthetic Communications, 2016. 46(24): p. 2022-2030. ISI[000389330900007].
[WOS]. TB_01_2017.

Patent Citations

28. Substituted Phenyloxazolidinones for Antimicrobial Therapy. Cooper, C.B., H. Huang, D. Zhang, N. Fotouhi, and T. Kaneko. Patent. 2017. 2016-US42486 2017015106: 227pp.

[Patent]. TB_01_2017.


29. Preparation of Heterocyclic Compounds as Antibacterial Agents. Guillemont, J.E.G., M.M.S. Motte, P.J.-M.B. Raboisson, and A. Tahri. Patent. 2017. 2016-EP65503 2017001661: 84pp.

[Patent]. TB_01_2017.


30. Preparation of Heterocyclic Compounds as Antibacterial Agents. Guillemont, J.E.G., M.M.S. Motte, P.J.-M.B. Raboisson, and A. Tahri. Patent. 2017. 2016-EP65499 2017001660: 194pp.

[Patent]. TB_01_2017.


31. Phenazine Derivatives as Antimicrobial Agents. Huigens, R.W., III, A. Grarrison, and Y. Abouelhassan. Patent. 2017. 2016-US42439

2017011730: 251pp.

[Patent]. TB_01_2017.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2024